Latest Als News

Neurizon Therapeutics reports encouraging topline results from its Phase 1 Open-Label Extension study of NUZ-001, demonstrating long-term safety and a significant survival advantage in ALS patients. These findings pave the way for the pivotal HEALEY ALS Platform Trial planned for late 2025.

MetalsTech Limited has completed critical in-adit channel sampling for its Sturec Gold Project, progressing its Pre-Feasibility Study (PFS) on track for late 2025 completion. The company is leveraging technological innovations to enhance recoveries and reduce environmental impact.

Connected Minerals has kicked off its Phase 2 reverse circulation drilling at the Ondapanda Prospect within Namibia’s Etango North-East Uranium Project, building on promising Phase 1 results that revealed multiple economic-grade uranium intersections.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper®, marking a significant step in commercialising sustainable mining products.

Papyrus Australia has signed a binding term sheet with TBS Mining Solutions to produce a biodegradable version of the Collar Keeper®, marking a major step in sustainable mining innovation.

European Lithium Ltd reports robust 2024 diamond drill results from its Tanbreez Rare Earth Project in Greenland, confirming consistent high-grade rare earth mineralisation with significant heavy rare earth content and promising associated metals.

Pioneer Lithium has completed extensive sampling at its Skull Creek Uranium Project in Colorado, revealing large-scale radiometric anomalies that suggest significant uranium potential. The company is now awaiting assay results and preparing for drilling amid supportive US uranium policies.

Metal Bank Limited is fast-tracking gold production at its Livingstone project in Western Australia, leveraging near-surface resources and existing processing infrastructure, while advancing copper and critical minerals exploration in Saudi Arabia.

Sky Metals has reported outstanding ore sorting results from bulk samples at its Tallebung Tin Project, achieving significant tin grade upgrades and mass reductions that promise to lower future mining costs.

Lode Resources has reported a second batch of high-grade drill results from its Montezuma Antimony & Silver Project in Tasmania, revealing significant polymetallic mineralisation and promising bulk tonnage potential.

Neurizon Therapeutics faces a delay in FDA review for its lead ALS therapy NUZ-001, with a new decision expected by early October amid agency-wide staffing challenges.

Advance Metals Limited has reported strong assay results from its maiden diamond drilling program at the Yoquivo Silver-Gold Project in Mexico, revealing high-grade silver-gold mineralisation extending 60-70 metres deeper in the Pertenencia Vein. These findings pave the way for potential resource upgrades.